Indefinite Delivery Contract SPE2DB20D9127

The Defense Logistics Agency (DLA) awarded a $499,999,999 Indefinite Delivery Contract (IDC) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The IDC, under the SPE2DB program, enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide.

The delivery orders awarded under this IDC cover a diverse portfolio of pharmaceutical products, such as Jakafi, Mirena, Xolair, Nucala, Keytruda, Trikafta, Cabometyx, and various other specialized medications and medical supplies. These orders do not have set-aside designations, allowing DMS Pharmaceutical Group to leverage its woman-owned small business status to secure direct federal awards across multiple product categories and medical domains. The delivery orders are predominantly firm fixed-price contracts with performance periods extending through November 2026, positioning DMS Pharmaceutical Group as a crucial supplier in the federal pharmaceutical supply chain.